Dr. Timothy Atkinson
Pharm.D., BCPS, CPE
Timothy is a Clinical Pharmacy Pain Specialist and federal employee in a regional referral pain clinic near Nashville, Tennessee. Dr. Atkinson specializes in complex and high-risk pain medication management through direct patient care and electronic consult services. He is a Residency Director for a PGY-2 Pain and Palliative Care Pharmacy Residency program and strong advocate for expansion of clinical pharmacists with expertise in collaborative drug therapy management (CDTM) specific to pain management. Dr. Atkinson is the Executive Director for the PROMPT Education Foundation which is a non-profit dedicated to restoring balance to pain and opioid education. He is also the owner of Vanguard Pain Management Consulting where he advises clients in managed care and the pharmaceutical industry His research interests include opioid equivalencies, serum level monitoring, pain management in specialty disease states, and the elderly.
Dr. Jacqueline Cleary
Dr. Cleary graduated from Furman University with a bachelor’s Degree of Biochemistry in 2010 and received her Pharm.D. in 2014 from the South Carolina College of Pharmacy, MUSC campus. She completed her post-graduate year one general pharmacy residency training with Sentara Medical System in Norfolk, VA and then completed her post-graduate year two pain and palliative care residency training at the Albany Stratton VA Medical center in Albany, NY. She is also board certified in ambulatory care pharmacy.
Dr. Cleary is currently an Assistant Professor at the Albany College of Pharmacy and Health Sciences in the Department of Pharmacy Practice. Her current practice site is Saratoga Hospital Medical Group Community Health Center in Saratoga Springs, NY. Dr. Cleary serves as clinical pharmacist specializing in primary care with a focus in pain management. She is also an Adjunct Professor at SAGE Graduate School of Nursing and serves as the pharmacology course coordinator. Recent national attention to the opioid epidemic has been an increasing subject of interest for Dr. Cleary. She has numerous posters, publications and has presented both locally and nationally on the topics of pain management, pharmacogenetics, naloxone, and risk mitigation strategies to reduce opioid abuse and misuse.
Dr. Amelia Persico
Dr. Persico graduated from Union Graduate College with an MBA in healthcare management in 2016 and Albany College of Pharmacy & Health Sciences with a Doctor of Pharmacy in 2017. She practiced as a community pharmacy manager for one year before pursuing clinical training at the Stratton VA Medical Center in Albany, New York. Dr. Persico completed her PGY-1 general practice pharmacy residency in June 2019 and is currently a PGY-2 in Pain Management and Palliative Care at the same institution. She continues to work part-time in community pharmacy where she enjoys the fast-paced environment and the opportunity to serve as a resource to patients in their own communities.
Dr. Persico first became interested in pain management during an APPE rotation with Dr. Fudin and Dr. Wegrzyn in January of 2016. She has since worked with Dr. Fudin and the rest of the team on multiple publications, posters and blog posts. She looks forward to collaborating more throughout her PGY-2 and beyond. Her current research interests include opioid safety, quality improvement, opioid dose tapering practices, and new developments in pain management. Outside of pharmacy Dr. Persico enjoys spending time with family, gardening, cooking and her two cats, Pickle and Meeka.
Dr. Thien Pham
Dr. Thien Pham is a Clinical Pharmacy Specialist in Pain Management practicing in the greater Los Angeles/Orange County area of Southern California and expert legal witness/consultant with REMITIGATE, LLC. Dr. Pham is a Navy Veteran who served his enlistment training at the Naval Hospital Corpsman School in Great Lakes, Illinois and Naval School of Health Sciences in Portsmouth, Virginia and was stationed at the Naval Hospital in Okinawa, Japan and Ambulatory Care Center in New Orleans, Louisiana. After his five-year enlistment as a Hospital Corpsman and Pharmacy Technician, Dr. Pham returned to California, where he earned his Associate of Science from Riverside City College, Bachelor of Science in Biochemistry from the University of California, Riverside, and Doctor of Pharmacy from Touro University, California.
Dr. Pham completed his Post Graduate Year 1 (PGY1) Pharmacy Residency at the VA Palo Alto Health Care System in Palo Alto, California and Post Graduate Year 2 (PGY2) in Pain & Palliative Care Pharmacy Residency at the Stratton VA Medical Center in Albany, New York. He is certified in Basic Life Support (BLS), received his teaching certificate from the Albany College of Pharmacy, Pain Management Practice Based certificate from the New York State Council of Health-system Pharmacists (NYSCHP), Advanced Practice Pharmacist (APh) certificate from the California Board of Pharmacy, and is an avid naloxone overdose kit educator. Dr. Pham has lectured live and by Webinar on various pain-related topics to physicians, pharmacists, nurses, and students.
In addition to his clinical and teaching duties, Dr. Pham has been actively involved with drafting manuscripts for publication in peer-reviewed journals such as American Society of Addiction Medicine, Journal of Pain Medicine, Journal of Pain Research, Journal of Medical Clinics of North America, PAINWeek Journal, Practical Pain Management, and Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.
Dr. Erica Wegrzyn
Dr. Erica Wegrzyn is a clinical pharmacy specialist in pain management at the Stratton VA Medical Center in Albany, New York, specializing in chronic noncancer pain and palliative care with collaboration in an interdisciplinary team. She is adjunct faculty with Western New England University College of Pharmacy and Albany College of Pharmacy and Health Sciences. Dr. Wegrzyn has numerous publications and is an Associate Editor-in-Chief for the Journal of Pain Research. Her research interests include buprenorphine and other unique opioids as an alternative to traditional opioids, opioid transition and dosing, in-home naloxone distribution, emergency response, and technology platforms to promote opioid safety.
Dr. Jeffrey J. Bettinger
Dr. Jeffrey J. Bettinger, PharmD, is the Senior Strategy Consultant and Therapeutics Associate for Remitigate, LLC, and is a Pain Management Pharmacist Specialist at Saratoga Hospital in Saratoga, NY.
Dr. Bettinger has worked for Remitigate for 3 years and has been integral in its development and expansion over that time. He oversees review of various medical documents for plaintiff or defense, including but not limited to insurance claims and litigation. He also continues to work closely with Remitigate’s CEO, Dr. Jeff Fudin in the ongoing evolution of Remitigate as the company sets to build upon its prior success and flourish in the clinical realm.
Dr. Bettinger earned his PharmD from Albany College of Pharmacy and Health Sciences in 2017 with a concentration in nephrology. Following his doctoral training, he completed a PGY1 general practice residency at the Stratton VA Medical Center in Albany, NY. Immediately following his general practice residency, he trained with Drs. Fudin and Wegrzyn and completed a PGY2 Pain and Palliative Care residency at the same institution. He continues to have a strong academic background publishing in peer-reviewed journals, presenting at regional and national meetings, and teaching various classes at different colleges of pharmacy. He also mentors students and residents at his clinical sites of practice and plans on continuing this mentorship as he transitions to Saratoga Hospital.
Dan Jochnowitz serves as our outside General Counsel. Dan is an experienced corporate, commercial transactions and IP specialist with over 30 years of in-house and private practice experience, where he has assisted technology and biotech companies, banks, developers, universities and other organizations in the U.S. and in various other countries including China, Russia, France, Australia, Thailand, Malaysia, Ecuador and Vietnam.
Dan’s practice includes a wide variety of complex technology and intellectual property transactions such as licensing agreements, research and development collaborations, manufacture and supply arrangements, distribution and reseller arrangements, sales rep agreements, SaaS subscription arrangements, service level arrangements, source code escrow arrangements, consumer and end-user facing agreements (e.g., website and mobile app terms of service, privacy policies and other end user license agreements), non-disclosure agreements, consulting and professional services agreements, and other arrangements and agreements involving the commercial exploitation of technology and intellectual property.